自动提醒与医生通知促进肾移植受者免疫抑制治疗依从性:一项随机试验
该随机对照试验将120例单中心肾移植受者按1:1:1分为三组:定制提醒组、定制提醒+医生通知组、单纯无线药瓶对照组。结果显示三组平均依从性分别为78%、88%和55%,两个干预组均显著高于对照组(P<0.001),但各组他克莫司血药浓度无显著差异。作者认为这些策略有前景,但仍需以临床结局为终点的试验评估。
要点
- 定制提醒+医生通知组平均依从性88%,定制提醒组78%,均高于对照组55%(P<0.001)。
- 三组他克莫司平均血药浓度无显著差异。
- 研究未评估临床终点,参与者和研究协调员未对干预分组设盲。
核心结论
- 医生通知和定制提醒在帮助患者提高用药依从性方面似乎有前景,但这些策略需要在以检测临床结局差异为把握度的试验中评估。
研究设计与样本
- 随机对照试验,纳入单中心肾移植受者120例,按1:1:1随机分组。
主要发现
- 定制提醒组、定制提醒+医生通知组和对照组平均依从性分别为78%、88%和55%,各干预组与对照组比较P<0.001。
- 三组他克莫司平均血药浓度无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究未评估临床终点。
- 参与者和研究协调员未对干预分组设盲。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immunosuppression nonadherence increases the risk for kidney transplant loss after transplantation. Wireless-enabled pill bottles have created the opportunity to monitor medication adherence in real time. Reminders may help patients with poor memory or organization. Provision of adherence data to providers may motivate patients to improve adherence and help providers identify adherence barriers. STUDY DESIGN: Randomized controlled trial. SETTING & PARTICIPANTS: Kidney transplant recipients (n=120) at a single center. INTERVENTION: Participants were provided wireless pill bottles to store tacrolimus and record bottle openings. Participants were randomly assigned 1:1:1 to adherence monitoring with customized reminders (including alarms, texts, telephone calls, and/or e-mails), monitoring with customized reminders plus provider notification (every 2 weeks, providers received notification if adherence decreased to <90% during that period), or wireless pill bottle use alone (control). OUTCOMES: The main outcome was bottle-measured tacrolimus adherence during the last 90 days of the 180-day trial. A secondary outcome was tacrolimus whole-blood concentrations at routine clinical visits. MEASUREMENTS: Adherence for the primary outcome was assessed via wireless pill bottle openings. RESULTS: Mean participant age was 50 years; 60% were men, and 40% were black. Mean adherence was 78%, 88%, and 55% in the reminders, reminders-plus-notification, and control arms (P<0.001 for comparison of each intervention to control). Mean tacrolimus levels were not significantly different between groups. LIMITATIONS: The study did not assess clinical end points. Participants and study coordinators were not blinded to intervention arm. CONCLUSIONS: Provider notification and customized reminders appear promising in helping patients achieve better medication adherence, but these strategies require evaluation in trials powered to detect differences in clinical outcomes.
引用
- Reese PP, Bloom RD, Trofe-Clark J, et al. Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial. Am J Kidney Dis. 2016. PMID: 27940063. doi:10.1053/j.ajkd.2016.10.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。